Zobrazeno 1 - 10
of 254
pro vyhledávání: '"Fehlmann, D."'
Autor:
Uluckan Ö; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation; Novartis Pharma AG, CH-4056, Basel, Switzerland., Bruno S; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation; Novartis Pharma AG, CH-4056, Basel, Switzerland., Wang Y; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation; Novartis Pharma AG, CH-4056, Basel, Switzerland., Wack N; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation; Novartis Pharma AG, CH-4056, Basel, Switzerland., Wilzopolski J; Institut für Pharmakologie und Toxikologie, Veterinärmedizin, Freie Universität Berlin, Koserstraße 20, 14195, Berlin, Germany; Bundesinstitut für Risikobewertung, Experimentelle Toxikologie und ZEBET, Diedersdorfer Weg 1, 12277, Berlin, Germany., Goetschy JF; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation; Novartis Pharma AG, CH-4056, Basel, Switzerland., Delucis-Bronn C; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation; Novartis Pharma AG, CH-4056, Basel, Switzerland., Urban B; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation; Novartis Pharma AG, CH-4056, Basel, Switzerland., Fehlmann D; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation; Novartis Pharma AG, CH-4056, Basel, Switzerland., Stark H; Heinrich Heine University Düsseldorf, Institute of Pharmaceutical and Medicinal Chemistry, Universitätsstr. 1, 40225, Düsseldorf, Germany., Hauchard A; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation; Novartis Pharma AG, CH-4056, Basel, Switzerland., Roussel E; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation; Novartis Pharma AG, CH-4056, Basel, Switzerland., Kempf D; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation; Novartis Pharma AG, CH-4056, Basel, Switzerland., Kaupmann K; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation; Novartis Pharma AG, CH-4056, Basel, Switzerland., Raulf F; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation; Novartis Pharma AG, CH-4056, Basel, Switzerland., Bäumer W; Institut für Pharmakologie und Toxikologie, Veterinärmedizin, Freie Universität Berlin, Koserstraße 20, 14195, Berlin, Germany., Röhn TA; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation; Novartis Pharma AG, CH-4056, Basel, Switzerland., Zerwes HG; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation; Novartis Pharma AG, CH-4056, Basel, Switzerland. Electronic address: hans-guenter.zerwes_ext@novartis.com.
Publikováno v:
European journal of pharmacology [Eur J Pharmacol] 2023 Apr 15; Vol. 945, pp. 175533. Date of Electronic Publication: 2023 Jan 21.
Publikováno v:
In Neuropharmacology 2002 42(3):396-413
Autor:
Velcicky J; Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland., Wilcken R; Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland., Cotesta S; Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland., Janser P; Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland., Schlapbach A; Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland., Wagner T; Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland., Piechon P; Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland., Villard F; Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland., Bouhelal R; Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland., Piller F; Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland., Harlfinger S; Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland., Stringer R; Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland., Fehlmann D; Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland., Kaupmann K; Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland., Littlewood-Evans A; Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland., Haffke M; Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland., Gommermann N; Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2020 Sep 10; Vol. 63 (17), pp. 9856-9875. Date of Electronic Publication: 2020 Aug 28.
Autor:
Bongiorni, Silvia1 (AUTHOR) bongiorni@unitus.it, Catalani, Elisabetta2 (AUTHOR) ecatalani@unitus.it, Arisi, Ivan3,4 (AUTHOR) i.arisi@ebri.it, Lazzarini, Francesca1 (AUTHOR) francesca.lazzarini@studenti.unitus.it, Del Quondam, Simona2 (AUTHOR) simona.delquondam@unitus.it, Brunetti, Kashi2 (AUTHOR) kashi.brunetti@unitus.it, Cervia, Davide2 (AUTHOR) d.cervia@unitus.it, Prantera, Giorgio1 (AUTHOR) prantera@unitus.it
Publikováno v:
Biomolecules (2218-273X). Jul2024, Vol. 14 Issue 7, p855. 18p.
This study investigated how the administration (acute and chronic) of the antidepressants citalopram and desmethylimipramine (DMI) influences somatostatin (somatotropin release inhibitory factor, SRIF) levels and SRIF receptor density (sst1-5) in rat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::3d454001b39403c6cdd11e68fd19bdcd
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3062177
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3062177
Autor:
Haffke M; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland. matthias.haffke@novartis.com.; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland. matthias.haffke@novartis.com., Fehlmann D; Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland., Rummel G; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland., Boivineau J; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland., Duckely M; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland., Gommermann N; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland., Cotesta S; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland., Sirockin F; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland., Freuler F; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland., Littlewood-Evans A; Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland., Kaupmann K; Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland. klemens.kaupmann@novartis.com., Jaakola VP; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland. veli-pekka.jaakola@confotherapeutics.com.; Confo Therapeutics, Zwijnaarde, Belgium. veli-pekka.jaakola@confotherapeutics.com.
Publikováno v:
Nature [Nature] 2019 Oct; Vol. 574 (7779), pp. 581-585. Date of Electronic Publication: 2019 Oct 23.
Autor:
He, Yijun1,2 (AUTHOR), Han, Yuanyuan2,3 (AUTHOR), Zou, Lijun1,2 (AUTHOR), Yao, Tingting1,2 (AUTHOR), Zhang, Yan1,2 (AUTHOR), Lv, Xin2,3 (AUTHOR), Jiang, Mao1,2 (AUTHOR), Long, Lingzhi1,2 (AUTHOR), Li, Mengyu1,2 (AUTHOR), Cheng, Xiaoyun2,4 (AUTHOR), Jiang, Guoliang1,2 (AUTHOR), Peng, Zhangzhe2,3,5 (AUTHOR), Tao, Lijian2,3,5 (AUTHOR), Meng, Jie1,2,5 (AUTHOR) mengjie@csu.edu.cn, Xie, Wei6 (AUTHOR) 13907315874@163.com
Publikováno v:
Scientific Reports. 6/22/2024, Vol. 14 Issue 1, p1-18. 18p.
Autor:
Huang, Xiaomin1 (AUTHOR), Wang, Ting1 (AUTHOR), Wang, Ludan1 (AUTHOR), Sun, Yantao1 (AUTHOR), Zhang, Ziru1 (AUTHOR), Zhang, Yajun1 (AUTHOR) zhangyj@nwu.edu.cn
Publikováno v:
BMC Chemistry. 5/3/2024, Vol. 18 Issue 1, p1-15. 15p.
Autor:
Moneta, D., Richichi, C., Aliprandi, M., Dournaud, P., Dutar, P., Billard, J. M., Carlo, A. S., Viollet, C., Hannon, J. P., Fehlmann, D., Nunn, C., Hoyer, D., Epelbaum, J., Vezzani, A.
Publikováno v:
European Journal of Neuroscience; Sep2002, Vol. 16 Issue 5, p843-849, 7p, 3 Charts
Autor:
Jacobson LH; Florey Institute of Neuroscience and Mental Health, Parkville, VIC, 3052, Australia. laura.jacobson@florey.edu.au.; Department of Pharmacology and Therapeutics, University of Melbourne, Parkville, VIC, 3052, Australia. laura.jacobson@florey.edu.au., Hoyer D; Florey Institute of Neuroscience and Mental Health, Parkville, VIC, 3052, Australia.; Department of Pharmacology and Therapeutics, University of Melbourne, Parkville, VIC, 3052, Australia.; Department of Chemical Physiology, The Scripps Research Institute, La Jolla, CA, 92037, USA., Fehlmann D; Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4002, Basel, Switzerland., Bettler B; Department of Biomedicine, Pharmazentrum, University of Basel, CH-4056, Basel, Switzerland., Kaupmann K; Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4002, Basel, Switzerland., Cryan JF; APC Microbiome Institute, University College Cork, Cork, Ireland. j.cryan@ucc.ie.; Department of Anatomy and Neuroscience, University College Cork, Western Gateway Building, Cork, Ireland. j.cryan@ucc.ie.
Publikováno v:
Psychopharmacology [Psychopharmacology (Berl)] 2017 May; Vol. 234 (9-10), pp. 1511-1523. Date of Electronic Publication: 2017 Jan 09.